vs
IRIDEX CORP（IRIX）与NexPoint Real Estate Finance, Inc.（NREF）财务数据对比。点击上方公司名可切换其他公司
IRIDEX CORP的季度营收约是NexPoint Real Estate Finance, Inc.的1.3倍（$14.7M vs $11.1M），NexPoint Real Estate Finance, Inc.同比增速更快（-48.8% vs -69.7%）
IRIDEX Corporation是一家全球性医疗科技企业，主要研发、生产和销售面向眼科及医疗美容领域的激光类医疗设备，产品供应至北美、欧洲、亚太等地区的医疗机构与诊所，为眼部疾病治疗和医美项目提供微创解决方案。
NexPoint Real Estate Finance, Inc.是一家总部位于美国的商业地产金融企业，主要为多户住宅、写字楼、工业及酒店物业提供结构化融资方案，运营并管理抵押贷款及其他地产相关投资组合，为利益相关方提供经风险调整的稳定回报。
IRIX vs NREF — 直观对比
营收规模更大
IRIX
是对方的1.3倍
$11.1M
营收增速更快
NREF
高出20.9%
-69.7%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $14.7M | $11.1M |
| 净利润 | — | $24.0M |
| 毛利率 | 37.2% | — |
| 营业利润率 | — | — |
| 净利率 | — | 216.6% |
| 营收同比 | -69.7% | -48.8% |
| 净利润同比 | — | 58.7% |
| 每股收益（稀释后） | — | $0.47 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收IRIXNREF
| Q4 25 | $14.7M | $11.1M | ||
| Q3 25 | $12.5M | $12.5M | ||
| Q2 25 | $13.6M | $12.1M | ||
| Q1 25 | $11.9M | $11.5M | ||
| Q4 24 | $12.7M | $21.7M | ||
| Q3 24 | $11.6M | $12.5M | ||
| Q2 24 | $12.6M | $6.7M | ||
| Q1 24 | $11.8M | $-12.8M |
净利润IRIXNREF
| Q4 25 | — | $24.0M | ||
| Q3 25 | $-1.6M | $50.9M | ||
| Q2 25 | $-994.0K | $22.3M | ||
| Q1 25 | $-1.7M | $26.0M | ||
| Q4 24 | $-834.0K | $15.2M | ||
| Q3 24 | $-1.9M | $23.3M | ||
| Q2 24 | $-2.7M | $12.1M | ||
| Q1 24 | $-3.5M | $-14.6M |
毛利率IRIXNREF
| Q4 25 | 37.2% | — | ||
| Q3 25 | 32.1% | — | ||
| Q2 25 | 34.5% | — | ||
| Q1 25 | 42.5% | — | ||
| Q4 24 | 44.0% | — | ||
| Q3 24 | 37.3% | — | ||
| Q2 24 | 40.7% | — | ||
| Q1 24 | 37.9% | — |
营业利润率IRIXNREF
| Q4 25 | — | — | ||
| Q3 25 | -11.3% | — | ||
| Q2 25 | -6.9% | — | ||
| Q1 25 | -1.7% | — | ||
| Q4 24 | -3.9% | — | ||
| Q3 24 | -16.1% | — | ||
| Q2 24 | -20.9% | — | ||
| Q1 24 | -28.0% | — |
净利率IRIXNREF
| Q4 25 | — | 216.6% | ||
| Q3 25 | -12.6% | 407.0% | ||
| Q2 25 | -7.3% | 184.5% | ||
| Q1 25 | -14.2% | 225.6% | ||
| Q4 24 | -6.6% | 69.9% | ||
| Q3 24 | -16.7% | 186.4% | ||
| Q2 24 | -21.2% | 179.7% | ||
| Q1 24 | -29.5% | 114.3% |
每股收益（稀释后）IRIXNREF
| Q4 25 | — | $0.47 | ||
| Q3 25 | $-0.09 | $1.14 | ||
| Q2 25 | $-0.06 | $0.54 | ||
| Q1 25 | $-0.10 | $0.70 | ||
| Q4 24 | $-0.05 | $0.71 | ||
| Q3 24 | $-0.12 | $0.74 | ||
| Q2 24 | $-0.16 | $0.40 | ||
| Q1 24 | $-0.21 | $-0.83 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $6.0M | $31.1M |
| 总债务越低越好 | — | $771.2M |
| 股东权益账面价值 | — | $388.0M |
| 总资产 | $29.2M | $5.3B |
| 负债/权益比越低杠杆越低 | — | 1.99× |
8季度趋势，按日历期对齐
现金及短期投资IRIXNREF
| Q4 25 | $6.0M | $31.1M | ||
| Q3 25 | $5.6M | $17.9M | ||
| Q2 25 | $6.8M | $9.1M | ||
| Q1 25 | $7.2M | $19.2M | ||
| Q4 24 | $2.4M | $3.9M | ||
| Q3 24 | $3.9M | $34.7M | ||
| Q2 24 | $4.1M | $4.3M | ||
| Q1 24 | $5.4M | $13.5M |
总债务IRIXNREF
| Q4 25 | — | $771.2M | ||
| Q3 25 | — | $720.9M | ||
| Q2 25 | — | $815.6M | ||
| Q1 25 | — | $831.5M | ||
| Q4 24 | $1.0M | $799.3M | ||
| Q3 24 | $1.4M | $815.5M | ||
| Q2 24 | — | $861.0M | ||
| Q1 24 | — | $843.3M |
股东权益IRIXNREF
| Q4 25 | — | $388.0M | ||
| Q3 25 | $4.7M | $375.4M | ||
| Q2 25 | $6.1M | $348.2M | ||
| Q1 25 | $852.0K | $343.7M | ||
| Q4 24 | $2.1M | $336.5M | ||
| Q3 24 | $2.6M | $335.8M | ||
| Q2 24 | $4.2M | $327.5M | ||
| Q1 24 | $6.5M | $327.1M |
总资产IRIXNREF
| Q4 25 | $29.2M | $5.3B | ||
| Q3 25 | $28.4M | $5.3B | ||
| Q2 25 | $31.6M | $5.4B | ||
| Q1 25 | $34.2M | $5.4B | ||
| Q4 24 | $29.1M | $5.4B | ||
| Q3 24 | $30.2M | $5.7B | ||
| Q2 24 | $31.2M | $6.6B | ||
| Q1 24 | $34.1M | $7.1B |
负债/权益比IRIXNREF
| Q4 25 | — | 1.99× | ||
| Q3 25 | — | 1.92× | ||
| Q2 25 | — | 2.34× | ||
| Q1 25 | — | 2.42× | ||
| Q4 24 | 0.48× | 2.38× | ||
| Q3 24 | 0.53× | 2.43× | ||
| Q2 24 | — | 2.63× | ||
| Q1 24 | — | 2.58× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $-4.5M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | -0.19× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流IRIXNREF
| Q4 25 | — | $-4.5M | ||
| Q3 25 | $-1.2M | $8.1M | ||
| Q2 25 | $-397.0K | $3.3M | ||
| Q1 25 | $-1.1M | $16.0M | ||
| Q4 24 | $-1.2M | $4.4M | ||
| Q3 24 | $-3.1M | $14.7M | ||
| Q2 24 | $-1.3M | $-7.5M | ||
| Q1 24 | $-1.6M | $17.7M |
自由现金流IRIXNREF
| Q4 25 | — | — | ||
| Q3 25 | $-1.2M | — | ||
| Q2 25 | $-410.0K | — | ||
| Q1 25 | $-1.2M | — | ||
| Q4 24 | $-1.2M | — | ||
| Q3 24 | $-3.1M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $-1.7M | — |
自由现金流率IRIXNREF
| Q4 25 | — | — | ||
| Q3 25 | -9.4% | — | ||
| Q2 25 | -3.0% | — | ||
| Q1 25 | -9.8% | — | ||
| Q4 24 | -9.8% | — | ||
| Q3 24 | -26.5% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | -14.0% | — |
资本支出强度IRIXNREF
| Q4 25 | — | — | ||
| Q3 25 | 0.1% | — | ||
| Q2 25 | 0.1% | — | ||
| Q1 25 | 0.1% | — | ||
| Q4 24 | 0.1% | — | ||
| Q3 24 | 0.0% | — | ||
| Q2 24 | 0.0% | — | ||
| Q1 24 | 0.0% | — |
现金转化率IRIXNREF
| Q4 25 | — | -0.19× | ||
| Q3 25 | — | 0.16× | ||
| Q2 25 | — | 0.15× | ||
| Q1 25 | — | 0.62× | ||
| Q4 24 | — | 0.29× | ||
| Q3 24 | — | 0.63× | ||
| Q2 24 | — | -0.62× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
